Stay updated with breaking news from Joint Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today announced that for the eleventh consecutive year, it has been selected as a TSMC Open Innovation Platform®...
MOUNTAIN VIEW, Calif., Nov. 3, 2021 -- Synopsys, Inc. today announced that for the eleventh consecutive year, it has been selected as a TSMC Open
Nano One and Euro Manganese have entered into a Joint Development Agreement. Nano One is a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries, and Euro Manganese is a battery raw materials company developing a significant manganese deposit...
Nano One® Materials Corp., a clean technology company that owns patented processes for affordable and low-environmental footprint production of high-performance cathode materials utilized in lithium-ion batteries, and Euro Manganese, a battery raw materials company developing a considerable manganese deposit in the Czech Republic, have entered into a Joint Development Agreement.
Message : Required fields TOKYO, July 29, 2021 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Michel Vounatsos, "Biogen") today announced results of a longitudinal preliminary assessment of the clinical effects of lecanemab (development code: BAN2401) — granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) in June 2021 — following 18 months of treatment in the open-label extension (OLE) of the Phase 2b proof-of-concept study in subjects ...